The global satellite imaging for agriculture market was valued at $516.1 million in 2022, and it is expected to grow with a CAGR of 7.50% during the forecast period 2023-2028 to reach $785.3 million by 2028. The growth in the global satellite imaging for agriculture technology market is expected to be driven by the increasing need for efficient and sustainable agriculture practices.

Market Introduction

Satellite-based agricultural imaging refers to the utilization of satellite-derived data for remote monitoring, management, and control of crop conditions, soil quality, and other agricultural parameters. Through the analysis of satellite imagery, farmers can assess soil characteristics, track crop health, and identify susceptibility to diseases, pests, and other risks.

The integration of satellite imaging into precision agriculture practices has significantly enhanced sustainability and intelligence in the field. Recognizing the potential of satellite imaging in agriculture, the United Nations Food and Agriculture Organization (FAO) acknowledges the need for improved management of global agricultural resources, especially in developing nations.

Industrial Impact

In the agricultural domain, satellite imagery can be integrated with a range of complementary technologies to facilitate the monitoring and management of agricultural resources. The combination of global positioning system (GPS) technology and satellite image distribution enables researchers and farmers to effectively track and oversee agricultural activities.

High-resolution satellite technologies provide crucial information for achieving profitability, efficiency, and sustainability in farming practices. Remote sensing using unmanned aerial vehicles (UAVs) for image capture, processing, and analysis has significantly impacted the agricultural sector. By combining these technologies with satellite imagery, farmers can enhance their overall agricultural operations.

The global market for satellite imaging technology in agriculture is set to benefit significantly from the advancement of small satellite constellations. These constellations consist of multiple compact satellites working collaboratively to provide high-resolution and high-frequency satellite services, delivering crucial information for achieving profitable, efficient, and sustainable agricultural practices.

In comparison to traditional satellite systems, small satellite constellations offer notable advantages, including cost reduction, shorter revisit intervals, and enhanced image resolution. These factors have substantially improved farmers’ accessibility to satellite imagery, enabling its integration into sustainable farming methods and precision agriculture.

In the global market for satellite imaging in agriculture, companies are proactively employing knowledge-driven strategies and technological innovations to establish themselves as market leaders. By adopting effective business or corporate strategies, these companies aim to maintain their relevance in the market and identify opportunities for growth. They strive to gain a competitive edge by implementing efficient business or corporate strategies that contribute to long-term profitability and ensure their future success.

Impact of the Russia-Ukraine Crisis

The conflict in Ukraine has heightened awareness regarding the use of satellite imagery to track crop losses and assess the impact of the war on food production. High-resolution satellite imagery has shed light on the attacks on Ukraine’s agricultural sector, underscoring the importance of monitoring the effects of armed conflict on farming.

NASA’s Harvest program has leveraged satellite imagery to provide valuable insights into the wheat harvest in Ukraine, particularly in the season following Russia’s invasion. The availability of commercial satellite data during conflicts proves instrumental in planning and mitigating food shortages, as demonstrated in the Ukraine crisis. Experts are increasingly recognizing the indispensable role of satellite imagery in tracking the influence of conflict on agriculture and ensuring effective response strategies.

Market Segmentation:

Segmentation 1: by Application

• Crop Health Monitoring
• Soil Mapping
• Forestry
• Others

Crop Health Monitoring to Continue its Dominance as the Leading Application Segment

The satellite imaging for agriculture market is led by the crop health monitoring segment, with a 41.1% share in 2022. Satellite imagery plays a pivotal role in the monitoring of crop health, enabling precise digital agriculture practices and large-scale pest detection. It empowers farmers and agronomists to monitor and optimize crop health and assess variations in yield on a seasonal basis.

By integrating satellite imagery with various datasets such as disease and pest models, yield maps, pest monitoring, and fertilization maps, a comprehensive crop monitoring system can be established. For example, in India, agri-traders have gained a competitive edge by estimating wheat yields at a state level 30 days prior to harvest, enabling informed decision-making regarding procurement and storage strategies.

By providing detailed imagery of remote areas, satellite imagery is providing researchers with the data they need to create accurate soil maps for areas that may otherwise have remained unmapped.

Satellite imagery is proving an effective tool that meets forestry management and research needs for cost-effective, up-to-date information on the status of forest resources. Scientists, governments, and non-governmental organizations have turned to satellite data to track deforestation, as well as to set targets for improvement. By providing a more comprehensive view of animal movements, this technology is allowing conservationists to better understand and protect migratory species.

Satellite imaging can be used to monitor carbon emissions, including those from forests and cities, in near-real-time through the integration of data from multiple satellites. Additionally, satellite imaging can be used to monitor weather patterns and changes, which can impact carbon sequestration and emissions.

Segmentation 2: by End User

• Agribusinesses
• Government and Non-Government Agencies
• Research Institutes
• Others

Agribusiness to Witness the Highest Growth between 2022 and 2028

The satellite imaging for agriculture market was dominated by the agribusiness segment in 2022 with a 66.6% share. Satellite image and remote sensing technology are improving every day, assisting farm managers and modern farmers in keeping track of conditions and monitoring growth, weather, and carbon. As the farms grow bigger in size, the satellite images give relevant data with newfound ease and surprising accuracy. They can help managers demonstrate their conservation and management efforts in an easily understandable and visually appealing way.

Governments and NGOs frequently use satellite images to analyze patterns of land use and plan for agricultural development, conservation, and other land use activities.

Crop models, which are mathematical representations of crop growth, yield, and response to environmental factors, can be developed and validated using satellite images. Researchers use these models to improve their understanding of crop biology and to create new crop varieties and management techniques.

More significant corporate players are searching for opportunities to buy and lease out various farming operations across the nation. Understanding historical management and conditions is crucial to these decisions, which has been made possible by satellite imagery and other remote sensing products. As a result, one can use the strength of time-series satellite imagery and remote sensing products to combine the expertise of farmers and farm managers with satellite data to tell a complete history of the farm and inspire confidence in the operation’s capability in investors.

Segmentation 3: by Product

• Data Acquisition
• Processing
• Analytics
• Integrated Delivery Platform

Integrated Delivery Platform to Witness the Highest Growth between 2022 and 2028

The satellite imaging for agriculture market is estimated to be led by the integrated delivery platform, and it held a share of 45.2% in 2022. For further use in analytics, acquired raw data must be processed to remove distortions (such as geographic, radiometric, and radiometric). Additionally, predefined coordinates and sensor specifications are followed when acquiring data. In order to interpret and analyze the data, the sensors gather the radiance and further process it into raw images. The various algorithms used in the geospatial analytics process integrate the various data and provide useful insights.

A significant constraint is developing a platform that can streamline communications between these systems and exchange mission-critical data continuously by integrating data from all applications, databases, and users.

Segmentation 4: by Region

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Italy, Netherlands, Switzerland, Belgium, Spain, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific – Japan, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific
• South America – Argentina, Brazil, and Rest-of-South America
• Middle East and Africa – South Africa, Turkey, Israel, and Rest-of-Middle East and Africa

North America, Europe, and the U.K. are the primary regions contributing to the global satellite imaging for agriculture market, and they collectively accounted for around 59% of the market share in 2022. The utilization of satellite imaging for precise crop health monitoring and pest detection is a key factor driving market growth in these regions. Asia-Pacific, including China, is gradually adopting satellite imaging for agriculture, supported by increasing research and development activities, experimental field studies, and government initiatives.

In the Middle East and Africa, the adoption of satellite imaging for agriculture is increasing due to technical training programs offered to farmers for adopting advanced precision agricultural technologies. In South America, the demand for food production with efficient input utilization and the emergence of start-ups are driving the adoption of satellite imaging for agriculture.

Recent Developments in the Satellite Imaging for Agriculture Market

• On March 2023, Esri partnered with Pollen Systems Corporation. Growers can manage their operations and make data-driven decisions by integrating geospatial data from various sources and gaining insights into the environmental and social impacts of their operations owing to the integration of PrecisionView Mobile with Esri’s ArcGIS platform.

• On March 2023, Satellogic partnered with SKYFI. Further democratizing geospatial data, the integration would increase users’ access to Satellogic’s Earth observation data.

• On March 2023, to broaden its data analysis platform and give its clients more insightful data, Planet Labs PBC acquired Sinergise.

• On March 2023, one of the first 30 cm HD global imagery base maps was produced by Maxar Technologies using more than 400,000 high-resolution satellite photos. It can be applied as a visually appealing contextual overlay as well as for extracting and recognizing features, making maps, producing 3D data for simulations, and more.

Demand – Drivers and Limitations

Market Demand Drivers:

Increasing Requirements from the Insurance Sector

In the realm of payment claims management, crop insurance companies are progressively incorporating satellite imagery as a valuable tool to assess the magnitude and extent of crop damage. An accurate and unbiased view of a crop’s status and potential can be obtained from satellite imagery, which can assist insurers in making more informed choices regarding crop insurance claims.

Increasing Farm Consolidation

The proliferation of satellite imagery in agricultural applications is projected to surge in response to the growing trend of farm consolidation. As farms expand in size, the integration of remote sensing technology would enable managers to effectively monitor various aspects such as growth, weather conditions, and other relevant factors. Moreover, identifying underutilized or suboptimal areas would empower farmers to consolidate these areas and increase overall productivity and operational efficiency.

High Benefits over Other Remote Sensing Technology and Infield Monitoring Technology

By incorporating satellite data into sophisticated algorithms, it is also possible to measure a variety of characteristics, including yield and crop growth stage, using satellite imagery. Satellite imagery can also aid farmers in understanding a variety of farming-related issues, such as areas that require more or less irrigation, the areas where their livestock graze, where to apply fertilizer, and the effects of changing weather patterns.

Need for Sustainable Agriculture Practices

In several ways, satellite imagery in agriculture supports the need for sustainable agricultural practices. First, crop health and growth rates can be tracked using satellite imagery, which can assist farmers in maximizing inputs and minimizing the use of pesticides and fertilizers. Second, land use and changes in vegetation cover can be tracked using satellite imagery, which can be used by farmers to identify underutilized or underused land. Deforestation and other types of land-use changes may not be as necessary as a result of more effective land use.

Market Challenges:

Technical Challenges in Obtaining and Analyzing Satellite Imagery

Even though satellite imagery has long been used in the agriculture industry, many developing nations still lack knowledge and understanding of the technology. This ignorance and lack of understanding may limit the use of satellite imagery in agriculture and prevent farmers from benefiting from its advantages. Although satellite imagery offers data for agricultural practices, crop types, and the corresponding outcome variables over lengthy time periods, farmers in developing nations might lack the technical know-how or expertise to effectively access and use the data.

Geopolitical Issues

High-resolution satellite imagery is restricted from being accessed for agricultural purposes due to national security, political, and privacy concerns, among other geopolitical issues. Additionally, some nations might not have the resources or infrastructure necessary to access and use satellite imagery efficiently, which can restrict the extent to which farmers in those nations can take advantage of satellite imagery’s advantages in agriculture.

Limited Understanding and Awareness Across Developing Countries

Israel and the U.S. are two nations that limit access to high-resolution satellite imagery. While access to high-resolution satellite imagery in Israel has historically been constrained due to national security concerns, production of satellite imagery with a resolution finer than 0.31 m is prohibited in the U.S.

Market Opportunities:

Rising Threat of Climate Risk

Satellite imagery is employed to tackle climate risks in agriculture. It aids in precision agriculture, enabling farmers to manage their environment sustainably. Remote sensing combines satellite data with field samples for a comprehensive agricultural landscape overview. Decision-makers can utilize satellite data for climate-sensitive matters like land use and water management.

Artificial Intelligence and Machine Learning in Action

By advancing crop production, raising agricultural efficiencies, enhancing crop yields, and cutting costs associated with food production, AI and ML are revolutionizing satellite imagery in agriculture. In order to predict crop yields, ML analyzes sensor data and historical trends, aiding farmers in the practice of precision farming. To help farmers monitor, manage, and protect crops from extreme weather conditions, diseases, pests, and other threats, satellite imagery can be combined with other cutting-edge solutions, such as the Internet of Things.

Tapping Small Holding Farmers with Affordable Solutions

The free use of satellite imagery on services such as Amazon Web Services (AWS) is one of the cost-effective solutions offered to smallholder farmers by satellite imaging. This can improve efficiency and help farmers conserve water and fertilizer. Additionally, utilizing satellite data and machine learning can promote smallholder farmers’ financial inclusion. Farmers can inform their decision-making for improving crop production and revenue while reducing environmental impact by using precision agriculture, which is based on intensive data collection with local sensor-based technology and remotely sensed imagery. Smallholder farmers need an ecosystem of contextually relevant software applications, though, in order to truly benefit from these advancements.

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The product segment helps the reader understand the different technologies used for satellite imaging for agriculture and their potential globally. Moreover, the study gives the reader a detailed understanding of the different solutions provided by the satellite imaging technology providers, such as imaging, processing, and analyzing. Compared to conventional agricultural methods, satellite imaging technology enables more exact targeting of planting, soil mapping, and forestry, allowing farmers to save money by maximizing the use of their inputs.

Growth/Marketing Strategy: The global satellite imaging for agriculture market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been partnerships, collaborations, and joint ventures to strengthen their position in the global satellite imaging for agriculture market. For instance, on March 2023, Satellogic partnered with SKYFI to further democratize geospatial data. The integration would increase users’ access to Satellogic’s Earth observation data.

Competitive Strategy: Key players in the global satellite imaging for agriculture market analyzed and profiled in the study involve satellite imaging technology-based product manufacturers, including market segments covered by distinct product kinds, applications served, and regional presence, as well as the influence of important market tactics employed. Moreover, a detailed competitive benchmarking of the players operating in the global satellite imaging for agriculture market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

The top leading players include the public companies operating in the global satellite imaging for agriculture market, which had a market share of around 62% in 2021. The rest of the market share, 38%, was taken by the private and start-up companies.

Key Companies Profiled

Company Type 1: Public Companies
• Airbus
• Farmers Edge Inc
• Planet Labs PBC
• Satellogic
• Syngenta
• Maxar Technologies

Company Type 2: Private Companies
• Descartes Labs, Inc
• EOS Data Analytics,Inc
• Esri
• European Space Imaging
• Gamaya
• ICEYE
• NaraSpace Inc
• Open Cosmos Ltd
• Satellite Imaging Corporation
• SkyWatch
• SpaceKnow Inc.
• EarthDaily Analytics
• SatSure
• SpaceSense
• Synspective

The post Satellite Imaging for Agriculture Market – A Global and Regional Analysis: Focus on, Application, End User, Product, and Region – Analysis and Forecast, 2023-2028 first appeared on CRI Report.

The global defense outlook showcases the defense budget of 30 countries for the period 2023-2033. The cumulative defense budget is valued to be $29,031.67 billion for the period 2023-2033. The global defense market is expected to be driven by geo-political activities, technological investment in autonomous and cyber capabilities, the emergence of public and private defense industries, and contracts by the national governments, among other factors.

Global Defense Outlook: Market Lifecycle Stage

The global defense market is in the maturity stage of its life cycle, characterized by a consolidated industry, slowing growth, and increased competition for a shrinking pool of defense spending.

Impact (Overview)

The defense industry is responsible for producing the equipment and technologies that are used by military forces around the world. One of the primary effects of the defense market on the global defense scenario is that it drives innovation and technological advancement. Companies that compete in the defense market are constantly developing new and better ways to protect soldiers, vehicles, and installations, as well as to detect, track, and engage enemy targets. This innovation helps to ensure that military forces are better equipped to confront the challenges of modern warfare. The defense market also helps to shape alliances and partnerships between countries. Countries that purchase defense equipment from a particular supplier often develop close ties with that supplier, which can lead to increased cooperation on other issues. Additionally, the defense market can create dependencies between countries, as some countries may rely on others for critical military capabilities. Finally, the defense market can have an impact on global economic and political stability. Defense spending represents a significant portion of many countries’ budgets, and the health of the defense market can have implications for government finances and employment. Additionally, the proliferation of advanced defense technologies can create security challenges, as countries may seek to acquire these technologies for their own military programs.

Overall, the defense market is a critical component of the global defense scenario, and its size, health, and trends can have far-reaching implications for countries and international security.

Country Analysis

• U.S.
• China
• Russia
• India
• Germany
• Australia
• U.K.
• Saudi Arabia
• France
• South Korea
• Japan
• Italy
• Canada
• Ukraine
• U.A.E.
• Turkey
• Israel
• Poland
• Brazil
• Taiwan
• Netherlands
• Spain
• Singapore
• Algeria
• Indonesia
• Oman
• Kuwait
• Colombia
• Pakistan
• Norway

Recent Developments in the Defense Industry

• On 20th April 2023, Rheinmetall Defence and Lockheed Martin entered into a memorandum of understanding (MOU) to collaborate on a tailored solution to provide Germany with a unique rocket artillery system, maximizing existing and combat-proven components produced in Germany.
• On 20th April 2023, BAE Systems signed a contract with Ritek AS to produce two new CV90 variants for the Swedish Armed Forces. The work would be carried out in cooperation with BAE Systems Hägglunds, with the delivery scheduled between 2023 and 2027.
• On 19th April 2023, the U.S. Defense Advanced Research Projects Agency (DARPA) awarded BAE Systems with a $8.3 million contract to develop an advanced autonomy system to speed operational planning under the Strategic Chaos Engine for Planning, Tactics, Experimentation, and Resiliency (SCEPTER) program. The program is designed to develop machine-generated strategies, evaluated within trusted simulation environments with thorough human review.
• On 13th April 2023, Boeing unveiled its Protected Wideband Satellite (PWS) design featuring Boeing’s Protected Tactical SATCOM Prototype (PTS-P) payload hosted aboard the U.S. Space Force’s Wideband Global SATCOM (WGS)-11 spacecraft with automated anti-jam capabilities to stay connected in a contested environment.
• On 13th April 2023, Boeing and the Defense Acquisition Program Administration (DAPA) of the Republic of Korea (ROK) signed a memorandum of understanding (MoU) to jointly research, develop, and market advanced weapons systems.
• On 12th April 2023, Saab signed a contract with the Swedish Defence Materiel Administration (FMV) for the support and maintenance services for the JAS 39 Gripen C/D fighter aircraft. The order is valued at $29.93 million and ensures continued operation and a cost-effective solution regarding the maintenance and availability of the system.
• On 14th February 2023, Thales Australia partnered with RGM Maintenance (RGM) and Queensland SME to help optimize and advance specialized heavy vehicle maintenance and regional access to services and maintenance of Land Materiel for the Australian Defence Force (ADF).
• On 29th March 2023, the French Navy’s Lorraine multi-mission frigate was enhanced with air defense capabilities (FREMM DA) which successfully fired the Aster 30 air defense missile.
• On 28th March 2023, the NATO Support and Procurement Agency (NSPA) ordered an additional Airbus A330 Multi-Role Tanker Transport (MRTT), increasing the Multinational MRTT Fleet (MMF) to 10 aircraft.
• On 10th January 2023, Airbus and VDL Group signed a partnership for the manufacturing and development of a laser communication terminal for aircraft, known as UltraAir. The two companies will have scheduled the preparation of a demonstration of the prototype’s first flight test in 2024.

Demand – Drivers and Limitations

Following are the drivers for the global defense market:

• Rising Procurement of Multi-Mission Helicopters and Fighter Jets to have Positive Impact on Market
• Increasing Penetration of Autonomous Systems in Military Applications

Following are the challenges for the global defense market:

• Long Gestation Periods and High Import Dependency for Procurement of Defense Equipment
• High Manufacturing Cost Associated with Integration and Implementation of Air and Space Systems

Following are the opportunities for the global defense market:

• Rise of Internet of Military Things and Era of Digital Battlefield: Future and its Potential
• Ageing Fleet

How can this report add value to an organization?

Platform/Innovation Strategy: The defense industry uses a variety of strategies to develop and strategize the land, air, sea, and space domains. These include investing in research and development, collaborating with academic institutions and other companies, leveraging emerging technologies such as artificial intelligence and robotics, and adapting commercial technologies for military use. Additionally, defense companies are focused on developing integrated systems that can operate across multiple domains, as well as enhancing the cybersecurity and resilience of their systems in the face of evolving threats.

Growth/Marketing Strategy: To grow the global defense market, the key players are observed to build strong relationships with customers and collaborate with other defense companies in the form of joint ventures or partnerships while working on their branding and advertising, which is boosted by the wide reach of digital marketing. Key players often engage with governments and participate in trade shows and exhibitions, further driving the growth of the global defense industry.

Key Companies Profiled

• Lockheed Martin Corporation
• Raytheon Technologies Corporation
• The Boeing Company
• Northrop Grumman Corporation
• BAE Systems
• Airbus S.A.S
• Thales Group
• Embraer SA
• Leonardo S.p.A.
• Textron Systems Aviation
• Dassault Aviation
• General Dynamics
• Saab AB
• Tactical Missiles Corporation
• MBDA Missile System

The post Defense Outlook – A Global and Regional Analysis: Focus on Key Enabling Technologies, Geo-Political Risks, and Country – Analysis and Forecast, 2023-2033 first appeared on CRI Report.

The global bio-LNG market was valued at $618.4 million in 2022 and is anticipated to reach $3,607.2 million by 2032, witnessing a CAGR of 20.3% during the forecast period 2023-2032.

The demand for bio-LNG is anticipated to grow with the increasing demand from end-use industries such as automotives, ships, and others. Furthermore, it is anticipated that during the projected period of 2023-2032, there will be an increasing adoption of bio-LNG in the automobile industry, and several governments are expected to implement policies and incentives to encourage the production and use of bio-LNG in various regions. For instance, the European Union has been setting targets to increase the use of renewable energy in the transport sector. In addition, the European Union has introduced the Alternative Fuels Infrastructure Directive, which aims to support the development of infrastructure for alternative fuels such as bio-LNG. However, the high cost of bio-LNG as compared to LNG is anticipated to hinder market growth in the future.

Market Lifecycle Stage

The global bio-LNG market is in the growth phase. Rising sales of vehicles and increasing focus on decarbonization and controlling pollutants are expected to boost the market growth. Furthermore, the increasing numbers of LNG trucks and rising environmental concerns are creating significant growth opportunities for bio-LNG. Bio-LNG is an inexhaustible substitute for conventional fuel and is one of the best options to meet the rising need for energy while reducing greenhouse gas emissions. Therefore, owing to the aforementioned factors, its demand is increasing. Moreover, the global bio-LNG market is expected to benefit from favorable government policies, which are expected to promote market expansion. The requirement for bio-LNG is being stimulated by ships as well.

Industrial Impact

• Growing demand for decarbonization is the main driving force behind the growing consumer interest in bio-LNG. As a result, these fuels are getting prominence in a variety of industries, including buses, trucks, ships, and others. One area where their implementation has been significantly greater is trucks and ships, which is expected to create opportunities for both existing market participants and market entrants.
• Furthermore, bio-LNG has a moderate to high impact on end-user industries; however, in the upcoming future, with increased production of automobiles, ships, and other applications, the impact is anticipated to increase.

Impact of COVID-19

The bio-LNG market was affected moderately by COVID-19. The demand for energy in transportation and other industries has dramatically dropped because of business restrictions, travel bans, and border closures, which have led to a decrease in the use of bioenergy and other renewable sources. Similarly, disruptions in the transportation of raw materials and finished products have also impacted the bio-LNG supply chain. The pandemic has also impacted the funding of bio-LNG projects, as investors have become more cautious due to the uncertainty caused by the pandemic. Overall, the pandemic has had a significant impact on the bio-LNG market. It has also drawn attention to the significance of renewable energy sources and the necessity of resilience in the face of universal challenges.

Market Segmentation:

Segmentation 1: by Application

• Automotive
• Ships
• Others

Based on application, automotive led the global bio-LNG market in terms of value in 2022.

Segmentation 2: by Source

• Agriculture Residues
• Industrial Waste
• Household Waste
• Others

The global bio-LNG market was led by agriculture residues in terms of source by value in 2022.

Segmentation 3: by Region

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Netherlands, Italy, Scandinavian, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific and Japan – Japan, India, South Korea, Australia, and Rest-of-Asia-Pacific and Japan
• Rest-of-the-World – South America, and Middle East and Africa

In the global bio-LNG market, Europe dominates the market owing to several bio-LNG production facilities already operational and more in the pipeline. This is due to several factors, including the strong regulatory support for renewable energy and decarbonization in the region, the availability of feedstocks for bio-LNG production, and the high demand for low-carbon fuels in the transportation and shipping sectors.

Recent Developments in the Global Bio-LNG Market

• In February 2023, GREEN CREATE built manure-fed biomethane production facilities in Wijster, Netherlands. The plant produces renewable natural gas (RNG) from agricultural waste, specifically manure that can be further upgraded to bio-LNG, which can then be used as a low-carbon fuel in the transportation sector.
• In February 2023, Liqvis announced migration to bio-LNG for heavy-duty transportation starting in 2023 as it broadens its range of bio-LNG suppliers. Beginning in mid-2023, Liqvis would gradually migrate to CO2-neutral bio-LNG and sell it as a substitute fuel at its refueling facilities.
• In April 2023, the U.K.’s largest owner of bio-CNG and bio-LNG plants, Nottingham-based Roadgas, recently transferred its assets to Pretoria Energy Group, which is funded by Mercuria Clean Energy Investments. Roadgas provides customized on-site fuelling options using biomethane made in the U.K. Within five years, the firm aims to power more than 2,500 gas-fuelled trucks annually.

Demand – Drivers and Limitations

The following are the demand drivers for the global bio-LNG market:

• Rising Environmental Concerns
• Increasing Number of LNG Trucks

The market is expected to face some limitations as well due to the following challenges:

• Limited Availability of Feedstocks
• High Price of Bio-LNG as Compared to LNG

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader to understand the different sources involved in producing bio-LNG. Moreover, the study provides the reader with a detailed understanding of the global bio-LNG market based on the application (automotive, ships, and others). Bio-LNG is gaining traction in different applications on the back of sustainability concerns and less nitrogen oxide emissions. They are also being used for controlling greenhouse gas (GHG) emissions.

Growth/Marketing Strategy: The global bio-LNG market has seen major development by key players operating in the market, such as business expansions, partnerships, collaborations, mergers and acquisitions, and joint ventures. The favored strategy for the companies has been product developments, business expansions, and acquisitions to strengthen their position in the global bio-LNG market. For instance, in October 2022, Titan LNG announced a plan to produce around 200,000 tons of bio-LNG annually. At its location in the port of Amsterdam, Titan LNG is expected to construct and run the bio-LNG plant, enabling delivery to ships and trucks.

Competitive Strategy: Key players in the global bio-LNG market analyzed and profiled in the study involve bio-LNG manufacturers and the overall ecosystem. Moreover, a detailed competitive benchmarking of the players operating in the global bio-LNG market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, acquisitions, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, analyzing company coverage, product portfolio, and market penetration.

The global bio-LNG market has been segmented by different application, among which automotive captured around 66% of the market as of 2022, ships accounted for around 29%, and other end-use industries accounted for around 5% of the total demand in 2022 in terms of value.

Key Companies Profiled

• TotalEnergies SE
• Linde plc
• MAKEEN Energy
• Nordsol
• BoxLNG Pvt. Ltd
• Flogas Britain Limited
• DBG Group B.V.
• Gasum Ltd
• RUHE Biogas Service GmbH
• LIQVIS GmbH
• Andion Global Inc.
• Cycle0
• Titan LNG
• Alexela
• EnviTec Biogas AG
• Scandinavian Biogas Fuels International AB
• Scale Gas Solutions
• GREEN CREATE
• Biomet SpA
• Air Water Inc.

The post Bio-LNG Market – A Global and Regional Analysis: Focus on Application, Source, and Region – Analysis and Forecast, 2023-2032 first appeared on CRI Report.

The global single-cell multi-omics market is projected to reach $7.72 billion by 2033 from $1.43 billion in 2022, growing at a CAGR of 17.27% during the forecast period 2023-2033.

The market is driven by factors such as a rise in the number of large-scale genomics studies leveraging single-cell RNA sequencing (Sc-RNA), use of the single-cell multi-omics approach for screening and diagnostics of diseases leading to a shift toward personalized medicine, and the increasing use of single-cell multi-omics for drug development.

Market Lifecycle Stage

The global single-cell multi-omics market is developing. The global single-cell multi-omics market has witnessed several collaborations among the market players. The collaborations are aimed at combining capabilities, expanding the customer base, and marketing, among others.

The opportunity for growth of the global single-cell multi-omics market lies in expansion into new research applications, such as single-cell metabolomics.

Impact of COVID-19

The COVID-19 pandemic has significantly impacted the world’s healthcare sector, especially the single-cell multi-omics sector. The pandemic has caused changes in research priorities, supply chain interruptions, and regulatory process modifications that may have had an impact on the operations and activities of single-cell multi-omics.

The future impact of COVID-19 on the demand and supply across the global single-cell multi-omics market depends on the abilities of stakeholders to withstand unforeseeable scenarios in the future. The intensity of impact due to COVID-19 in the future will depend on the current efforts being made by companies to equip their supply chains with the necessary components and processes to remain responsive.

Market Segmentation:

Segmentation 1: by Sample Type

• Animal Sample
• Human Sample
• Microbial Sample

The global single-cell multi-omics market (by sample type) is expected to be dominated by the human sample segment.

Segmentation 2: by Techniques

• Single-Cell Isolation and Dispensing
• Single-Cell Analysis

The global single-cell multi-omics market (by techniques) is expected to be dominated by single-cell isolation and dispensing.

Segmentation 3: By Omics Type

• Single-Cell Transcriptomics
• Single-Cell Genomics
• Single-Cell Proteomics

The global single-cell multi-omics market (by omics type) is expected to be dominated by single-cell transcriptomics.

Segmentation 4: By Product Type

• Kits and Consumables
• Instruments
• Software

The global single-cell multi-omics market (by product type) is expected to be dominated by kits and consumables.

Segmentation 5: By Applications

• Clinical Research
• Translational Research
• Synthetic Biology

The global single-cell multi-omics market (by application) is expected to be dominated by clinical research.

Segmentation 6: By End User

• Biopharmaceutical and Biotech Companies
• Academic and Research Institutions
• Contract Research Organizations (CROs)

The global single-cell multi-omics market (by end user) is expected to be dominated by academic and research institutions.

Segmentation 7: by Region

• North America – U.S., Canada
• Europe – Germany, U.K., France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific – China, Japan, India, Australia, Singapore, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

The global single-cell multi-omics market (by region) is dominated by the North America region.

Recent Developments in Global Single-Cell Multi-Omics Market

• In February 2023, Singleron Biotechnologies and Macrogen Europe announced a strategic alliance to deliver outstanding single-cell multi-omics sequencing solutions, and they combined their strengths.
• In February 2023, Becton, Dickinson and Company announced a new instrument for single-cell multi-omics analysis that would enable scientists to run high-throughput studies without sacrificing sample integrity – potentially accelerating time to discovery across a wide range of disciplines, including immunology, genetic disease research, and cancer and chronic disease research.
• In December 2022, 10x Genomics, Inc. announced the first commercial shipments of its Xenium platform for in situ analysis. Xenium is the next generation of targeted spatial profiling of genes and proteins at subcellular resolution.
• In March 2023, Mission Bio partnered with the National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT), leveraging its Tapestri Platform to improve analytical assays and cell manufacturing processes.
• In December 2022, Mission Bio partnered with Abiosciences to co-develop bioinformatics packages for translational and clinical research applications in hematological cancers in China. The goal is to combine Mission Bio’s single-cell DNA and multi-omics capabilities with Abiosciences’ artificial intelligence technology to uncover new disease signatures and address therapeutic resistance.

Demand – Drivers and Limitations

The following are the drivers for the global single-cell multi-omics market:

• Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
• Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
• Increasing Use of Single-Cell Multi-Omics for Drug Development
• Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics

The market is expected to face some limitations as well due to the following challenges:

• High Cost of Single-Cell Analysis and Sequencing
• Limited Availability of Large Online Data Storage and Analysis Platforms

How can this report add value to an organization?

Growth/Marketing Strategy: The global single-cell multi-omics market has seen major development by key players operating in the market, such as new offerings, partnerships, collaboration, and joint ventures.

Competitive Strategy: The global single-cell multi-omics market has witnessed growth in recent years; as the field of single-cell multi-omics grows, it has witnessed increased collaboration between researchers, academic institutions, and industry partners to drive innovation and commercialization of these technologies. Single-cell multi-omics technologies are already being used in a variety of applications, such as cancer research, immunology, and neuroscience. As the technologies continue to improve, they may be applied to other areas of research, such as developmental biology and stem cell research.

Key Companies Profiled

• 10x Genomics, Inc.
• Becton, Dickinson and Company
• BICO GROUP AB (PUBL)
• Bio-Rad Laboratories, Inc.
• BGI Group
• Illumina Inc.
• Fluidigm Corporation
• Menarini Group
• Mission Bio
• Nanostring Technologies, Inc.
• Namocell, Inc.
• PhenomeX,inc.
• QIAGEN NV
• Rarecells Diagnostics
• Scipio Bioscience
• Shilps Sciences
• Singleron Biotechnologies
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Universal Sequencing Technology Corporation”

The post Single-Cell Multi-Omics Market – A Global and Regional Analysis: Focus on Product Type, Sample Type, Technique, Application, Omics Type, End User, and Country Analysis – Analysis and Forecast, 2023-2033 first appeared on CRI Report.

The global constrained peptide drugs market revenue has been forecasted from 2024 to 2040, following the earliest launch of the first constrained peptide drug in the market.

The market size is anticipated to be $0.06 billion in 2024 and is expected to reach $17.38 billion in 2040, growing at a CAGR of 38.94% during the forecast period 2025-2040.

Market Lifecycle Stage

The global constrained peptide drugs market is anticipated to witness tremendous growth during the forecast period 2025-2040, largely fuelled by the promise of a novel breakthrough constrained peptide pipeline, which is no longer restricted to receptor targets. Advancements in chemical technologies, the therapeutics’ success of commercialized synthetic peptides in recent years, and the affordable pricing being realized by these biomolecules in a wide range of diseases are some additional factors attributing to the projected growth in the forecast period.

Impact

The impact analysis for the factors that significantly affect the market, namely, drivers, restraints, and opportunities, has been provided on a short-term and long-term basis. The short-term assessment considers the period between 2020 and 2025, and the long-term assessment considers the period between 2026 and 2040. Key developments and strategies that have been undertaken by some of the key players in this market have been accounted for evaluation of the impact analysis. Further, these key developments have been assessed to understand the future scope of integrating advancing technologies to enable superior outcomes. Additionally, approvals and launches from companies and patent bodies have also been considered while evaluating the dynamics of the global constrained peptide drugs market.

Impact of COVID-19

In December 2019, Wuhan, a city in the Hubei region of China, was the site of the first detection of the COVID-19 outbreak. Following the classification of COVID-19 as novel pneumonia due to a cluster of unexplained pneumonia cases, efforts to pinpoint the culprit causing the outbreak and outline its genomic sequence got underway right once. The virus has already spread to every country on the globe, and researchers, governments, and business leaders are working to find answers to the crisis at a scale and speed that has never been seen. Testing for SARS-CoV-2 in the populace is one of the main steps that has been put into place globally, among many other measures used to stop the spread of the disease.

The global constrained peptide drugs market is a research-oriented market, having a majority of products in clinical trial stages. It primarily consists of clinical-stage biopharmaceutical companies and global biopharmaceutical companies such as Bicycle Therapeutics PLC, Protagonist Therapeutics, Inc., Aileron Therapeutics, Inc., Polyphor, and Santhera Pharmaceuticals Holding. Since most of the products are in the clinical phase of drug development, constrained peptide drug companies had a low impact on the COVID-19 pandemic.

Although clinical trials were brought to pause because of the lockdowns imposed by governments across the world, causing a delay in the clinical trial timeline, and volunteers and patients were also not able to participate in the clinical trials due to the lockdown; however, few companies took the opportunity of the pandemic and initiated the development of potential drugs against COVID-19. For instance, UCB Pharma participated in the COVID-19 Moonshot, an initiative to expedite the development of an anti-viral for COVID-19. The company’s Phase III investigational molecule Zilucoplan is being studied for acute respiratory distress syndrome associated with COVID-19. Another company, Polyphor Limited, is evaluating Balixafortide, a constrained peptide drug, against COVID-19 as it demonstrated strong efficacy in in-vitro models.

During the pre-COVID-19 period, the global constrained peptide drugs market observed 38 significant key developments. Out of the 38 key developments, the majority were funding activities, primarily focused on the development of novel antibiotics and support clinical trials of certain drugs in clinical phases. For example, in May 2019, Innosuisse awarded Polyphor Ltd. and the University of Zurich to escalate the development of novel antibiotics for treating infections caused by gram-negative bacteria. Furthermore, seven synergistic activities were undertaken in the global constrained peptide drugs market before COVID-19.

Market Segmentation:

Segmentation 1: by Peptide Type

• Disulfide-Rich Peptides (DRPs)
• Cyclic Peptides

Based on peptide type, the disulfide-rich peptides (DRPs) segment is anticipated to dominate the global constrained peptide drugs market in 2040 as the segment includes the pipeline-constrained peptide with either limited existing treatment options or no approved drugs for the disease.

Segmentation 2: by Region

• North America
• Europe
• Asia-Pacific

The North America region is anticipated to dominate the global constrained peptide drugs market (by region) during the forecast period 2025-2040. The reasons contributing to the high demand for constrained peptide drugs in North America are the increasing prevalence of target indications and the early launch of pipeline products in the U.S. and Canada.

Segmentation 3: by Potential Product

• BT5528
• Rusfertide (PTG-300)
• PN-943
• PN-235
• Zilucoplan (RA101495)

Segmentation 4: by Company

• Aileron Therapeutics, Inc.
• Bicycle Therapeutics plc
• Spexis AG
• Protagonist Therapeutics Inc.
• Santhera Pharmaceuticals
• Union Chimique Belge S.A. (UCB)
• Creative Peptides
• Biosynth (Pepscan)
• Pepticom Ltd.
• PeptiDream, Inc.
• Bio-Synthesis Inc
• CPC Scientific Inc.
• Circle Pharma
• Zealand Pharma
• Chugai Pharmaceutical Co., Ltd.

Based on the company, the global constrained peptide drugs market is dominated by 15 major companies.

Recent Developments in the Global Constrained Peptide Drugs Market

• In August 2021, Protagonist Therapeutics Inc. declared the resolution of its collaboration agreement with Zealand Pharma through the reduction of future milestone payments, sales milestones, and royalties owed to Zealand Pharma regarding Protagonist Therapeutics Inc.’s product candidate rusfertide under the terms of the 2012 collaboration agreement between the companies.
• In April 2021, Union Chimique Belge S.A. (UCB) anticipated the release of phase 3 key results for generalized myasthenia gravis (gMG) in the fourth quarter of 2021 and discontinued further development of zilucoplan for immune-mediated necrotizing myopathy (IMNM).
• In September 2021, Polyphor Limited and EnBiotix announced the successful closing of the purchase agreement for EnBiotix to acquire the inhaled antibiotic murepavadin.
• In November 2020, Pepscan Therapeutics B.V. was granted a license for the use of the proprietary CLIPS technology offered by Bicycle Therapeutics plc. The peptide-constraining technology would further help in the development of the company’s products named BT1718 and THR-149.
• In June 2020, Santhera Pharmaceuticals secured a financing commitment of up to $22.1 million from a fund managed by Highbridge Capital Management.

Demand – Drivers and Limitations

The following are the demand drivers for the global constrained peptide drugs market:

• Enhanced Binding Affinity and Cellular Uptake
• Development of Synthetic Constraining Method
• Limitations with Conventional Peptides
• Increasing Government and Private Funding

The market is expected to face some limitations due to the following challenges:

• Increased Competition from Biologics
• Risk of Immunogenic Effects and Unsatisfactory ADME Properties

How can this report add value to an organization?

Workflow/Innovation Strategy: The global constrained peptide drugs market has been segmented (by product) into five candidates, i.e., BT5528, Rusfertide (PTG-300), Zilucoplan (RA101495), PN-235, and PN-943. Over the past decade, peptide drug discovery and development has witnessed a renaissance and scientific thrust as the industry has come to acknowledge the capability of peptide therapeutics in addressing unmet medical needs and the potential of this class of molecules to become a significant accompaniment or even favored alternative treatment to biologics and small molecules.

Peptide therapeutics have demonstrated a novel and selective yet safe mode of action for a wide range of indications. The existing and future development of constrained peptide drugs will continue to burgeon upon the strengths of constrained peptides and innovative technologies employed in the discovery and development, including peptide drug conjugates, multifunctional peptides, and cell-penetrating peptides. Furthermore, limitations associated with presently available peptides have resulted in an urgent need for new design, administration, and synthesis in peptide therapeutics, thereby leading to advancements in the development of constrained peptides.

Growth/Marketing Strategy: Constrained peptides provide noteworthy advantages over linear peptides. An increase in interest in the field of constrained peptides due to the properties they offer led to advancements in peptide synthesis technologies. Companies such as PeptiDream Inc., Pepticom Ltd., Bicycle Therapeutics plc, and Polyphor Limited offer proprietary drug development and constrained peptide synthesis technologies. PeptiDream Inc.’s proprietary Peptide Discovery Platform System (PDPS) technology is used to synthesize synthetic non-native peptide libraries expeditiously, which helps in identifying peptides that can be used as potential drugs for a disease.

Competitive Strategy: Key players in the global constrained peptide drugs market have been analyzed and profiled in the study, including manufacturers involved in new product development, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global constrained peptide drugs market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

The post Constrained Peptide Drugs Market – A Global and Regional Analysis: Focus on Peptide Type, Product, and Region-Wise Analysis – Analysis and Forecast, 2024-2040 first appeared on CRI Report.

Market Overview

The Superplasticizers market is expected to reach USD 10.32 billion by 2030, to register a CAGR of 7.24% during the forecast period.

The rising demand for poly-carboxylates (PCE) superplasticizers is one of the main drivers fueling the market’s expansion. In the market for concrete admixtures, these new-generation superplasticizers are widely sought-after. Additionally, PCE superplasticizers have improved adaptability to cement, gypsum, and other ingredients, which minimizes surface flaws and enhances the visual appeal of concrete. They also don’t include any substances like chlorides, which might encourage steel corrosion.

PCE superplasticizers possess unique molecular structures as surfactants containing carboxyl-grafted copolymers. This structure grants them several advantages, including low dosage requirements, high water reduction rates, significant early strength growth, satisfactory slump retention, minimal impact on concrete shrinkage, and performance that remains unaffected by the order of addition. These extensive properties make PCE superplasticizers widely used in the construction sector, thereby driving the growth of the global superplasticizer market.

The growing utilization of precast concrete and ready-mix concrete further contributes to the market expansion. These construction methods require the use of superplasticizers to enhance workability, improve performance, and meet specific project requirements.

Overall, the superplasticizers market is experiencing steady growth due to the increasing demand for PCE superplasticizers and their widespread applications in the construction industry. The market is expected to continue its positive trajectory, driven by advancements in concrete technology and the need for more durable and efficient construction materials.

Market Segmentation

The reactor-type segment comprises Polycarboxylate (P.C.) Derivatives, Sulfonated Naphthalene Formaldehydes, Sulfonated Melamine Formaldehydes, and Modified Lignosulfonates.

Based on application, the Superplasticizers market is categorized into Ready-Mix Concrete (RMC), Precast Concrete, High-Performance Concrete (HPC), and Others.

Regional Insights

The Asia-Pacific Superplasticizers market represented USD 1.95 billion in 2021 and is supposed to expect a 7.75% CAGR during the review time frame. This is credited to development in the development and framework industry in the significant economies of the region.

Europe’s Superplasticizers market represents the second-biggest market because of the presence of central members in the region taking on different market procedures to grow the market impression in developing business sectors. Further, the Germany Superplasticizers market held the biggest piece of the pie and was the quickest-developing business sector in the European region.

The North America Superplasticizers Market should create at a CAGR of 7.06% from 2022 to 2030. North America is projected to hold an enormous share of the global market inferable from the rising designs and improvement industry in the region. Moreover, the US Superplasticizers market held the greatest market share, and it was the largest business creator in the North American region.

Major Players

In the Superplasticizers Market, Arkema, BASF SE, GCP Applied Technologies Inc., Sika AG, KAO Corporation, Mapei, Sika AG, HA-BE Betochemie, Arkema, and Chembond Chemicals Limited, Enaspol, Chembond Chemicals Limited, Rhein-Chemotechnik, and Rain Carbon, and Fritz-Pak Corporation.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 20

1.1 MARKET ATTRACTIVENESS ANALYSIS 22

1.1.1 SUPERPLASTICIZERS MARKET, BY TYPE 23

1.1.2 SUPERPLASTICIZERS MARKET, BY FORM 24

1.1.3 SUPERPLASTICIZERS MARKET, BY APPLICATION 25

1.1.4 SUPERPLASTICIZERS MARKET, BY REGION 26

2 MARKET INTRODUCTION 27

2.1 DEFINITION 27

2.2 SCOPE OF THE STUDY 27

2.3 MARKET STRUCTURE 28

3 RESEARCH METHODOLOGY 29

3.1 RESEARCH PROCESS 29

3.2 PRIMARY RESEARCH 30

3.3 SECONDARY RESEARCH 31

3.4 MARKET SIZE ESTIMATION 31

3.5 TOP-DOWN AND BOTTOM-UP APPROACH 32

3.6 FORECAST MODEL 33

3.7 LIST OF ASSUMPTIONS & LIMITATIONS 34

4 MARKET DYNAMICS 35

4.1 INTRODUCTION 35

4.2 DRIVERS 36

4.2.1 GROWING DEMAND FOR POLY-CARBOXYLATES (PCE) SUPERPLASTICIZER 36

4.2.2 GROWING USE OF PRECAST CONCRETE AND READY-MIX CONCRETE 37

4.3 RESTRAINTS 38

4.3.1 VOLATILE RAW MATERIAL PRICES 38

4.4 OPPORTUNITIES 40

4.4.1 GROWTH POTENTIAL IN BRICS REGION 40

4.5 CHALLENGES 41

4.5.1 ALTERNATIVES AVAILABLE IN MARKET 41

5 MARKET FACTOR ANALYSIS 42

5.1 SUPPLY CHAIN ANALYSIS 42

5.1.1 RAW MATERIAL SUPPLIERS 42

5.1.2 SUPERPLASTICIZER MANUFACTURERS 43

5.1.3 DISTRIBUTION & SALES CHANNEL 43

5.1.4 END USERS 43

5.2 PORTER’S FIVE FORCES ANALYSIS 44

5.2.1 THREAT OF NEW ENTRANTS 44

5.2.2 BARGAINING POWER OF SUPPLIERS 45

5.2.3 THREAT OF SUBSTITUTES 45

5.2.4 BARGAINING POWER OF BUYERS 45

5.2.5 INTENSITY OF RIVALRY 45

5.3 PRICING ANALYSIS (USD/TON), BY REGION, 2019–2021 46

5.4 IMPACT OF COVID 19 OUTBREAK ON SUPERPLASTICIZER MARKET 46

5.4.1 IMPACT OF COVID-19 ON THE SUPPLY CHAIN OF SUPERPLASTICIZER 46

5.4.2 IMPACT OF COVID-19 ON SUPERPLASTICIZER END-USE INDUSTRY 47

6 GLOBAL SUPERPLASTICIZERS MARKET, BY TYPE 48

6.1 OVERVIEW 48

6.2 POLYCARBOXYLATE (P.C.) DERIVATIVES 50

6.3 SULFONATED NAPHTHALENE FORMALDEHYDES 51

6.4 SULFONATED MELAMINE FORMALDEHYDES 52

6.5 MODIFIED LIGNOSULFONATES 53

7 GLOBAL SUPERPLASTICIZERS MARKET, BY FORM 54

7.1 OVERVIEW 54

7.2 LIQUID 56

7.3 POWDER 57

8 GLOBAL SUPERPLASTICIZERS MARKET, BY APPLICATION 58

8.1 OVERVIEW 58

8.2 READY-MIX CONCRETE (RMC) 60

8.3 PRECAST CONCRETE 61

8.4 HIGH-PERFORMANCE CONCRETE (HPC) 62

8.5 OTHERS 63

9 GLOBAL SUPERPLASTICIZERS MARKET, BY REGION 64

9.1 OVERVIEW 64

9.2 NORTH AMERICA 66

9.2.1 US 69

9.2.2 CANADA 71

9.3 EUROPE 73

9.3.1 GERMANY 76

9.3.2 RUSSIA 78

9.3.3 ITALY 80

9.3.4 FRANCE 82

9.3.5 SPAIN 84

9.3.6 UK 86

9.3.7 POLAND 88

9.3.8 BELGIUM 90

9.3.9 THE NETHERLANDS 92

9.3.10 REST OF EUROPE 94

9.4 ASIA PACIFIC 96

9.4.1 CHINA 99

9.4.2 INDIA 101

9.4.3 JAPAN 103

9.4.4 AUSTRALIA & NEW ZEALAND 105

9.4.5 SOUTH KOREA 107

9.4.6 INDONESIA 109

9.4.7 THAILAND 111

9.4.8 MALAYSIA 113

9.4.9 REST OF ASIA-PACIFIC 115

9.5 LATIN AMERICA 117

9.5.1 BRAZIL 120

9.5.2 MEXICO 122

9.5.3 ARGENTINA 124

9.5.4 REST OF LATIN AMERICA 126

9.6 MIDDLE EAST & AFRICA 128

9.6.1 TURKEY 131

9.6.2 SAUDI ARABIA 133

9.6.3 SOUTH AFRICA 135

9.6.4 UAE 137

9.6.5 ISRAEL 139

9.6.6 REST OF MIDDLE EAST & AFRICA 141

10 COMPETITIVE LANDSCAPE 143

10.1 COMPETITIVE OVERVIEW 143

10.2 RECENT DEVELOPMENTS, MERGERS/ACQUISITIONS 143

10.3 GLOBAL MARKET STRATEGY ANALYSIS 144

10.4 COMPETITIVE BENCHMARKING 145

11 COMPANY PROFILES 146

11.1 ARKEMA 146

11.1.1 COMPANY OVERVIEW 146

11.1.2 FINANCIAL OVERVIEW 147

11.1.3 PRODUCT OFFERED 147

11.1.4 KEY DEVELOPMENTS 148

11.1.5 SWOT ANALYSIS 148

11.1.6 KEY STRATEGIES 148

11.2 BASF SE 149

11.2.1 COMPANY OVERVIEW 149

11.2.2 FINANCIAL OVERVIEW 150

11.2.3 PRODUCTS OFFERED 150

11.2.4 BASF SE: KEY DEVELOPMENTS 151

11.2.5 SWOT ANALYSIS 151

11.2.6 KEY STRATEGIES 151

11.3 GCP APPLIED TECHNOLOGIES 152

11.3.1 COMPANY OVERVIEW 152

11.3.2 FINANCIAL OVERVIEW 153

11.3.3 PRODUCTS OFFERED 153

11.3.4 KEY DEVELOPMENTS 154

11.3.5 SWOT ANALYSIS 154

11.3.6 KEY STRATEGIES 154

11.4 KAO CORPORATION 155

11.4.1 COMPANY OVERVIEW 155

11.4.2 FINANCIAL OVERVIEW 156

11.4.3 PRODUCTS OFFERED 156

11.4.4 KEY DEVELOPMENTS 157

11.4.5 SWOT ANALYSIS 157

11.4.6 KEY STRATEGIES 157

11.5 HA-BE BETONCHEMIE (HA-BE) 158

11.5.1 COMPANY OVERVIEW 158

11.5.2 FINANCIAL OVERVIEW 158

11.5.3 PRODUCTS OFFERED 158

11.5.4 KEY DEVELOPMENTS 159

11.5.5 SWOT ANALYSIS 159

11.5.6 KEY STRATEGIES 159

11.6 SIKA AG 160

11.6.1 COMPANY OVERVIEW 160

11.6.2 FINANCIAL OVERVIEW 161

11.6.3 PRODUCTS OFFERED 161

11.6.4 KEY DEVELOPMENTS 162

11.6.5 SWOT ANALYSIS 163

11.6.6 KEY STRATEGIES 163

11.7 MAPEI SPA 164

11.7.1 COMPANY OVERVIEW 164

11.7.2 FINANCIAL OVERVIEW 165

11.7.3 PRODUCTS OFFERED 166

11.7.4 KEY DEVELOPMENTS 166

11.7.5 SWOT ANALYSIS 167

11.7.6 KEY STRATEGIES 167

11.8 ENASPOL A.S. 168

11.8.1 COMPANY OVERVIEW 168

11.8.2 FINANCIAL OVERVIEW 168

11.8.3 PRODUCTS OFFERED 168

11.8.4 KEY DEVELOPMENTS 168

11.8.5 SWOT ANALYSIS 169

11.8.6 KEY STRATEGIES 169

11.9 CHEMBOND CHEMICALS LIMITED 170

11.9.1 COMPANY OVERVIEW 170

11.9.2 FINANCIAL OVERVIEW 170

11.9.3 PRODUCT OFFERED 171

11.9.4 KEY DEVELOPMENTS 171

11.9.5 SWOT ANALYSIS 171

11.9.6 KEY STRATEGIES 172

11.10 RHEIN-CHEMOTECHNIK 173

11.10.1 COMPANY OVERVIEW 173

11.10.2 FINANCIAL OVERVIEW 173

11.10.3 PRODUCT OFFERED 173

11.10.4 KEY DEVELOPMENTS 173

11.10.5 SWOT ANALYSIS 174

11.10.6 KEY STRATEGIES 174

11.11 RAIN CARBON INC. 175

11.11.1 COMPANY OVERVIEW 175

11.11.2 FINANCIAL OVERVIEW 176

11.11.3 PRODUCT OFFERED 176

11.11.4 KEY DEVELOPMENTS 177

11.11.5 SWOT ANALYSIS 177

11.11.6 KEY STRATEGIES 177

11.12 FRITZ-PAK CORPORATION 178

11.12.1 COMPANY OVERVIEW 178

11.12.2 FINANCIAL OVERVIEW 178

11.12.3 PRODUCT OFFERED 178

11.12.4 KEY DEVELOPMENTS 178

11.12.5 SWOT ANALYSIS 179

11.12.6 KEY STRATEGIES 179

12 APPENDIX 180

12.1 REFERENCES 180

12.2 RELATED REPORTS 180

The post Global Superplasticizers Market Analysis and Forecast Report 2030 first appeared on CRI Report.

Market Overview

According to the report, the global Depression Screening Market is projected to register a notable Compound Annual Growth Rate (CAGR) of 5.89% during the review period. There are a few elements driving the development of the market are expanding the commonness of mental problems and ascending in the reception of new treatments and medicines.

The rising pervasiveness of mental problems across the globe is among the critical elements energizing the development of the depression screening market. As per the World Wellbeing Association (WHO), there has been a 13% expansion in emotional well-being conditions and other burdensome issues somewhat recently. Essentially, as per the US Division of Wellbeing and Human Administration (HHS), in 2020, it is assessed that 4.1 million young people ages 12 and 17 had a significant burdensome episode, and 2.9 million had a significant burdensome episode with serious hindrance. Hence, the rising number of patients with related messes is adding to the development in the worldwide market.

Market Segmentation

Major depressive disorder, anxiety distress, bipolar disorder, psychotic disorders, and other conditions are included in the indication-based segmentation of the depression screening market.

The diagnosis, psychological tests, blood tests, pharmacogenomic testing, and other factors have all been considered when segmenting the depression screening market.

The global depression screening market has been divided into three categories depending on end users: home-based, research and academic institutions, and hospitals and clinics.

Regional Analysis

North America depression screening market represented the biggest market share in 2021, because of variables credited to its enormous offer incorporating created healthcare foundation, expanding mechanical progression about emotional wellness, and the presence of countless

Market Players

Europe depression screening market represents the second-biggest market share attributable to the developing pervasiveness of various kinds of burdensome problems among people, and the rising consciousness of treating these burdensome illnesses are the central point that are driving the market development in Europe.

For example, as per the examination distributed by the Emergency clinic del Blemish Clinical Exploration Organization (IMIM) in July 2021, around 6.4% of the European populace experiences depression. Moreover, the German depression screening market held the biggest market share in 2021 and is the quickest developing during the gauge time frame.

The Asia-Pacific depression screening market is supposed to develop at a huge offer from 2022 to 2030. The region’s rising extra cash of people, expanding assets in research exercises, and rising commonness of mental problems is the central point that is driving the market development in Asia-Pacific. Also, Japan’s depression screening market held the biggest market share, and India is the quickest developing market during the gauge time frame.

Major Players

Key Companies in the Depression Screening Market include Medtronic (Ireland), Pearson (UK), PAR, Inc. (US), SIGMA Assessment Systems Inc. (US), Siemens Healthineers (Germany), Danaher Corporation (US), National Psychological Corporation (India), Bruker (US), Multi-Health Systems Inc. (US), Nedley Health (US), and Others.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA MINING

3.3 SECONDARY RESEARCH

3.4 PRIMARY RESEARCH

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF MENTAL DISORDERS

4.2.2 RISE IN ADOPTION OF NEW THERAPIES AND TREATMENTS

4.2.3 RISING NUMBER OF STRATEGIC INITIATIVES

4.3 RESTRAINTS

4.3.1 LACK OF AWARENESS AMONG PEOPLE

4.3.2 DEARTH OF QUALIFIED MENTAL HEALTH PROFESSIONALS

4.4 OPPORTUNITIES

4.4.1 INCREASING TECHNOLOGICAL ADVANCEMENT IN REGARD TO MENTAL HEALTH

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 PRODUCT DEVELOPMENT & BUSINESS ACQUISITION (PDBA)

5.1.2 SALES AND MARKETING

5.1.3 CONTRACT MANAGEMENT

5.1.4 CUSTOMER SERVICE & SUPPORT

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL DEPRESSION SCREENING MARKET

5.3.1 IMPACT ON MARKET GROWTH

5.3.2 IMPACT ON VALUE CHAIN

5.3.3 IMPACT ON END USERS

6 GLOBAL DEPRESSION SCREENING MARKET, BY INDICATON

6.1 OVERVIEW

6.2 MAJOR DEPRESSIVE DISORDER

6.3 ANXIETY DISTRESS

6.4 BIPOLAR DISORDER

6.5 PSYCHOTIC DISORDERS

6.6 OTHERS

7 GLOBAL DEPRESION SCREENING MARKET, BY DIAGNOSIS

7.1 OVERVIEW

7.2 PSYCHOLOGICAL TESTS

7.3 BLOOD TESTS

7.4 PHARMACOGENOMIC TESTING

7.5 OTHERS

8 GLOBAL DEPRESSION SCREENING MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS AND CLINICS

8.3 HOME-BASED

8.4 RESEARCH AND ACADEMIC INSTITUTES

9 GLOBAL DEPRESSION SCREENING MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 JAPAN

9.4.2 CHINA

9.4.3 INDIA

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL DEPRESSION SCREENING MARKET

10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL DEPRESSION SCREENING MARKET

10.5 KEY DEVELOPMENT ANALYSIS

10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL

10.6.2 PARTNERSHIP/AGREEMENT

10.6.3 MERGER /ACQUISTION

10.7 FINANCIAL MATRIX

10.7.1 SALES (USD MILLION), 2021

10.7.2 R&D EXPENDITURE (USD MILLION), 2021

11 COMPANY PROFILES

11.1 NATIONAL PSYCHOLOGICAL CORPORATION

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 KEY STRATEGIES

11.2 BRUKER

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 MEDTRONIC

11.3.1 COMPANY OVERVIEWS

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 MULTI-HEALTH SYSTEMS INC.

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 KEY STRATEGIES

11.5 NEDLEY HEALTH

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 KEY STRATEGIES

11.6 DANAHER CORPORATION

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 SWOT ANALYSIS

11.6.6 KEY STRATEGIES

11.7 PEARSON

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS/SERVICES OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 SWOT ANALYSIS

11.7.6 KEY STRATEGIES

11.8 SIGMA ASSESSMENT SYSTEMS INC.

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 KEY STRATEGIES

11.9 SIEMENS

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 SWOT ANALYSIS

11.9.6 KEY STRATEGIES

11.10 PAR, INC.

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

11.11 MYRIAD GENETICS, INC.

11.11.1 COMPANY OVERVIEW

11.11.2 FINANCIAL OVERVIEW

11.11.3 PRODUCTS OFFERED

11.11.4 KEY DEVELOPMENTS

11.11.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

The post Depression Screening Market Forecast to 2030 first appeared on CRI Report.

The global low-carbon aluminum market is projected to reach $119.97 billion by 2031 from $81.89 billion in 2022, growing at a CAGR of 4.3% during the forecast period 2022-2031.

The use of low-carbon aluminum is becoming more common in several industries, including transportation, building and construction, electrical engineering, foil and packaging, and others. The market is anticipated to benefit from the growing preference for lightweight materials over heavy metals, as this would enable weight reduction and foster market growth.

In the automobile industry, the demand for low-carbon aluminum is rising due to the increasing number of electric vehicles that are made from lightweight materials. Amongst all industries, the automotive industry has been majorly focusing on decarbonization and has been witnessing high adoption of low-carbon aluminum. Government securities are also pushing the adoption of low-carbon aluminum. It helps in the weight reduction of vehicles, which contributes significantly to vehicles’ fuel efficiency.

Further, the use of low-carbon aluminum helps reduce CO2 emission, which is an environment-friendly aspect of applications of low-carbon aluminum in the automobile industry. There is a growing trend in the aluminum industry toward investing in low-carbon aluminum production. This is driven by several factors, including increasing pressure from consumers and investors to reduce carbon emissions, as well as regulatory initiatives aimed at curbing greenhouse gas emissions.

Market Lifecycle Stage

The low-carbon aluminum market has been in its growth stage, and much has been attributed to the increasing need for carbon reduction in commodity products such as aluminum. The ecosystem of the low-carbon aluminum market comprises primary aluminum manufacturers, aluminum recyclers, aluminum value-added product manufacturers, OEMs, and end users. The market is still developing, with Europe at the forefront, followed by other regions such as North America, the Middle East and Africa, Asia-Pacific, China, and South America.

Industrial Impact

• The major advantages of low-carbon aluminum include its ability to reduce greenhouse gas emissions, increase energy efficiency, and improve the sustainability of the aluminum industry, among others. Additionally, low-carbon aluminum also offers improved properties compared to traditional aluminum, such as increased purity and strength. This offers a significant reason for the players to move toward low-carbon aluminum, reduce carbon dioxide emissions, and utilize the existing market infrastructure. Low-carbon aluminum has a high adoption rate in transportation, among other applications owing to the increased initiatives by automakers to decarbonize the industry.

• The major regions anticipated to use low-carbon aluminum are Europe and North America. Globally, there have been numerous partnerships between the manufacturers, suppliers, and end users of low-carbon aluminum, which has led to significant growth in the market.

Impact of COVID-19

The COVID-19 pandemic has had an adverse impact on most of the sectors globally, owing to countrywide lockdown, temporary shutdown of production facilities, and the slowdown of the global economy. The pandemic has shown a severe impact on transportation, building and construction, electrical, machinery, and equipment, among other industries.

However, applications such as foil and packaging, consumer goods, and others saw slight to considerable positive growth trends in FY2020. The industry saw a severe adverse impact in H1FY2020, along with some recovery in H2FY2020. Furthermore, the COVID-19 epidemic-related global lockdown led to production halts and disruptions in supply chains, manufacturing, and deployment activity, all of which had a detrimental effect on the market for low-carbon aluminum in 2020.

Market Segmentation:

Segmentation 1: by End User

• Transportation
• Building and Construction
• Electrical Industry
• Consumer Goods
• Foil and Packaging
• Machinery and Equipment
• Others

Based on end users, the low-carbon aluminum market is estimated to be led by the transportation segment during the forecast period 2022-2031.

Segmentation 2: by Source of Production

• Solar Energy
• Wind Energy
• Hydro Energy
• Recycling
• Carbon Capture and Storage (CCS)
• Others

Based on the source of production, the low-carbon aluminum market is estimated to be led by the recycling segment during the forecast period 2022-2031.

Segmentation 3: by Product

• Flat-Rolled
• Castings
• Extrusion
• Forgings
• Rod and Bar
• Others

Based on product, the low-carbon aluminum market is estimated to be led by the flat-rolled segment during the forecast period 2022-2031.

Segmentation 4: by Region

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Italy, Spain, Russia, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific and Japan – Japan, India, South Korea, ASEAN, and Rest-of-Asia-Pacific and Japan
• Rest-of-the-World – Middle East and Africa and South America

In the global low-carbon aluminum market, Europe and North America are anticipated to gain traction in terms of low-carbon aluminum production, owing to the presence of the world’s largest manufacturers in those regions.

Recent Developments in Low-Carbon Aluminum Market

• In April 2021, En+ Group announced that it had produced the world’s lowest carbon aluminum, in a major breakthrough for the industry. En+ Group Metals segment has successfully produced aluminum with the industry’s lowest carbon footprint – less than 0.01 tons of CO2 equivalent per ton of metal.

• In January 2023, Emirates Global Aluminium PJSC and leading beverage producer, can-maker, and waste management company, together announced the launch of Aluminium Recycling Coalition, which aims to drive a step-change in aluminum recycling in the U.A.E. Coalescing members include EGA, Abu Dhabi Waste Management Company (Tadweer), Aujan Coca-Cola Beverages Company, Coca-Cola Al Ahlia Beverages Company, BEEAH Tandeef, Pepsi-bottler Dubai Refreshment, CANPACK, Crown Bevcan EMEA, DULSCO Group, and Veolia.

• In August 2021, Vedanta Aluminium Business was India’s largest green power purchaser on the Green Market at the Indian Energy Exchange Limited (IEX) platform as of Q1 FY2021 and FY2022. Vedanta procured 354 million units of solar and non-solar renewable energy primarily from Green Term-Ahead Market (GTAM) at IEX for its largest integrated aluminum production facility at Jharsuguda, Odisha.

• In November 2021, Nordural Grundartangi ehf, a wholly owned subsidiary of Century Aluminum Company, commenced the construction of a new low-carbon billet casthouse at its Grundartangi, Iceland smelter. The new value-added casthouse would have a capacity of 150,000 tons of billet production and is expected to start production in the first quarter of 2024.

• In December 2022, Hydro and Mercedes-Benz collaborated on a joint technology roadmap aiming to develop aluminum solutions from 2023 to 2030 approved for automotive applications with a CO2 footprint below 3.0 kgCO2/kgAl.

Demand – Drivers and Limitations

The following are the demand drivers for low-carbon aluminum market:

• Increasing Attention of Governments toward Decarbonization of Core Contributing Commodities
• Growing Research and Development Activities to Achieve Near Zero Emissions

The market is expected to face some limitations due to the following challenges:

• Lower Recycling Rates for Aluminum in Various Industries
• Volatile Low-Carbon Aluminum Prices

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different sources of production and products involved in the low-carbon aluminum market. The source of production segment has been segmented into solar energy, wind energy, hydro energy, recycling, carbon capture and storage (CCS), and others. The product segment has been segmented into flat-rolled, castings, extrusion, forgings, rod and bar, and others. Moreover, the study provides the reader with a detailed understanding of the low-carbon aluminum market based on end users, including transportation, building and construction, the electrical industry, consumer goods, foil and packaging, machinery and equipment, and others. The increasing adoption of low-carbon aluminum in manufacturing components in sustainable technologies is expected to fuel the growth of the market.

Growth/Marketing Strategy: The low-carbon aluminum market has seen major development by key players operating in the market, such as business expansions, partnerships, collaborations, mergers and acquisitions, and joint ventures. The favored strategy for the companies has been business expansions to strengthen their position in the low-carbon aluminum market. For instance, in February 2022, Emirates Global Aluminium PJSC announced its plan to build a 150,000 tons per year aluminum recycling facility, the company’s first and set to be the largest in the U.A.E. The company intends to market recycled aluminum under the brand name EternAL.

Competitive Strategy: Key players in the low-carbon aluminum market analyzed and profiled in the study involve low-carbon aluminum producers and the overall ecosystem. Moreover, a detailed competitive benchmarking of the players operating in the low-carbon aluminum market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, acquisitions, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

Aluminum that has greenhouse gas (GHG) emission intensity below 4 tons of CO2 equivalent per ton of aluminum manufactured has been considered as low-carbon aluminum. To achieve this, renewable energy source is used in the manufacturing of primary aluminum. Furthermore, recycling aluminum further reduces energy consumption and CO2 emissions and can be considered low-carbon aluminum.

Among product segmentations, the flat-rolled segment dominated the low-carbon aluminum market in 2021 and is the largest segment owing to growing demand from end-use industries such as transportation, building and construction, and others. Flat-rolled products have high strength-to-weight ratios, are corrosion-resistant, durable, and can be recycled multiple times, which further reduces their environmental impact.

Some of the prominent producers of low-carbon aluminum are:

Company Type 1 (by Source of Production): Solar Energy
• Vedanta Aluminum and Power
• Emirates Global Aluminium PJSC
• Capral Limited
• Rio Tinto
• China Hongqiao Group Limited

Company Type 2 (by Source of Production): Hydro Energy
• EN+ Group
• Century Aluminum Company
• Norsk Hydro ASA
• Alcoa Corporation
• China Hongqiao Group Limited
• South32
• PT Indonesia Asahan Aluminium

Company Type 3 (by Source of Production): Recycling
• EN+ Group
• Century Aluminum Company
• Emirates Global Aluminium PJSC
• Norsk Hydro ASA
• Constellium SE

Company Type 4 (by Source of Production): Carbon Capture and Storage (CCS) (Planned)
• Aluminium Dunkerque
• Norsk Hydro ASA

Various players are involved in the market, which has been covered in different sections of the report.

The post Low-Carbon Aluminum Market – A Global and Regional Analysis: Focus on Source of Production, Product, End User, and Region – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

In 2022, the global functional genomics market was valued at $10.57 billion, and it is expected to reach $46.24 billion by 2033, growing at a CAGR of 14.04% during the forecast period 2023-2033.

The growth in the global functional genomics market is expected to be driven by its increased applications especially in targeted therapy and precision medicine.

Market Lifecycle Stage

Functional genomics is the study of genes and their interactions in different biological processes. The field aims to narrow down the candidate genes or regions from the entire genome that can be analyzed in detail to understand the working of various biological processes. The workings of individual components of a biological system including various interactions at the DNA, RNA, and proteins level is analyzed at the genotypic as well as the phenotypic level. The field is focused on the dynamics of gene products which can be at a specific developmental stage during a disease. Functional genomics is used to link phenotypes to genotypes using the study findings.

According to this report, functional genomics products are used in DNA level (epigenomics), RNA level (transcriptomics), protein level (proteomics) or metabolite level (metabolomics). This includes all the products used in these fields’ workflow before bioinformatics and data analysis. Together all these fields describe the transcripts, metabolites, and proteins of any biological system. The integration of all these pieces makes up the entire biological system that is being studied which makes up the field of functional genomics.

Impact

• For instance, in May 2022, Thermo Fisher Scientific, Inc. partnered with Qatar Foundation to develop a pan-Arab genotyping array. The intent behind this product launch was to be a cost-effective alternative to whole-genome sequencing and to provide greater diversity in genome-wide research studies under Qatar Genome Program.
• In September 2022, Illumina Inc. introduced the NovaSeqX Series (NovaSeq X and NovaSeq X Plus), which are next-generation sequencers designed for large-scale production. With the capability to sequence over 20,000 genomes per year, this new technology offers unparalleled accuracy and scalability.

Impact of COVID-19

In March 2019, the world was hit by a storm with the Sars-CoV-2 virus, which led to the entire world being shut down and everybody getting tested for the virus. As the amount of testing increased, it became important to increase the pace of testing as well. To do this, next-generation sequencers were set up at many clinical and diagnostic centers to sequence the genomes and transcriptomes of the virus as well as the infected patients to understand and procure treatments.

Recently, NGS technologies are increasingly being used for clinical diagnosis. The overall popularity of NGS sequencing for genome and transcriptome sequencing was increased during COVID-19 because of its use in the detection of coronavirus by the methods such as SARS-CoV-2 surveillance, detection, and the detection of new viruses.

In response to the COVID-19 pandemic and the impact on medical research at the National Institutes of Health (NIH) and the National Cancer Institute (NCI) both extended grant application deadlines, laid back reporting requirements, and offered flexibility on how the grant money is spent. The national government supported research work and offered medical researchers the flexibility to implement their skill set and knowledge in studying SARS-CoV-2. Due to this, the use of NGS during COVID-19 ended up increasing due to its use in COVID-19 testing.

In fact, even now, after the pandemic has subsided the effect lingers and the use of sequencing instruments is not expected to go down but to keep increasing over the next decade enhancing the fields for epigenomics, transcriptomics, proteomics and metabolomics as well.

Market Segmentation:

Segmentation 1: by Product
• Kits and Assays
• Instruments

As of 2022, the global functional genomics market (by product) was dominated by the kits and assays segment, holding a 58.12% market share.

Segmentation 2: by Technology
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Microarray
• Other

The global functional genomics market (by technology) is expected to be dominated by the next-generation sequencing (NGS) segment during the forecast period 2023-2033. This is because it is the most efficient and accurate technology currently available when it comes to gene analysis.

Segmentation 3: by Application
• Transcriptomics
• Epigenomics
• Proteomics
• Metabolomics

The global functional genomics market (by application) is expected to be dominated by the transcriptomics segment in the market during the forecast period 2023-2033. This is because this is one the oldest fields of functional genomics with much research and efficient tools already done, additionally it is easier to analyse RNAs as compared to proteins, thus the high revenue of this segment.

Segmentation 4: by End User
• Academic & Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Other End Users

As of 2022, the global functional genomics market (by end user) was dominated by the academic and research institutions segment, holding a 60.32% market share.

Segmentation 5: by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World

North America is expected to dominate the global functional genomics market with a revenue of $4.21 billion in 2022. However, the Asia-Pacific (APAC) region, constituting several emerging economies, is expected to register the highest CAGR of 15.27% during the forecast period 2023-2033.

Recent Developments in Global Functional Genomics Market

• In September 2022, Thermo Fisher Scientific partnerered with the joint effort of Acdemia Sinica and multiple hospitals across the country, i.e., Taiwan Precision Medicine Initiative (TPMI) to advance the next phase of the large-scale predictive genomics study. The intent behind this partnership was to support its goal of genotyping 1 million people in Taiwan. TPMI reached the milestone of enrolling more than 500,000 participants in July, making it the largest study of its kind outside of the United States and Europe.
• In March 2022, Thermo Fisher Scientific collaborated with Symphogen and Servier to provide biopharmaceutical discovery and development laboratories with advanced tools and simplified processes for effective analysis of intricate therapeutic proteins, thereby supporting their research efforts.
• In July 2021, Pacific Biosciences of California, Inc. has sighned a agreement to acquire Omniome. This acquitision is likley to expand the portfolio in epigenetics segments
• In October 2022, Oxford Nanopore Technologies introduced the new PromethION 2 (“P2”) Solo sequencer in the market. It is a high-yield sequencer that provides real-time whole genome sequencing, enabling more than just basic DNA analysis. With the capacity for comprehensive analysis of genetic variants, transcriptomic and epigenetic data on a single platform, this technology is aimed at driving scientific discovery to improve lives.
• In September 2022, Illumina Inc. introduced the NovaSeqX Series (NovaSeq X and NovaSeq X Plus), which are next-generation sequencers designed for large-scale production. With the capability to sequence over 20,000 genomes per year, this new technology offers unparalleled accuracy and scalability.

Demand – Drivers and Limitations

Following are the demand drivers for the global functional genomics market:

• Integration of Multi-omics Approaches for Patient Stratification
• Increasing Popularity of Epigenetics Leading to Vast Usage
• Increased Technological Advancements and Government Initiatives in the Functional Genomics Ecosystem

The market is expected to face some limitations too due to the following challenges:

• Limitation in Implementation of Data in Proteomics and Metabolomics
• Regulatory Compliance issues related to Functional Genomics Technology

How can this report add value to an organization?

Product/Innovation Strategy: The report considers functional genomics kits and assays-based companies. The industry is seeing constant development and product launches with new and innovative upgrades. Additionally, new discoveries of more efficient instruments and tools of functional genomics is increasing researchers’ trust in functional genomics.

Growth/Marketing Strategy: The key components in functional genomics are the kits and assays along with the instruments for sample analysis. The advancements in the overall fucntioncal genomics ecosystem are influencing the growth of this market.

Competitive Strategy: The key players in the global functional genomics market have been analyzed and profiled in the study, consisting of most product-based companies. Moreover, a detailed competitive benchmarking of the players operating in the global functional genomics market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, analyzing company coverage, product portfolio, and market penetration.

Key Companies Profiled

• Agilent Technologies, Inc.
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories, Inc.
• Danaher. (Integrated DNA Technologies, Inc.)
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Merck KGaA
• MRM Proteomics
• Pacific Biosciences of California, Inc.
• Promega Corporation
• QIAGEN
• Thermo Fisher Scientific Inc.

The post Functional Genomics Market – A Global and Regional Analysis: Focus on Product, Technology, Application, End User and Country Analysis – Analysis and Forecast, 2023-2033 first appeared on CRI Report.

The global NGS data storage market is projected to reach $6.96 billion by 2033 from $1.13 billion in 2022, growing at a CAGR of 18.02% during the forecast period 2023-2033.

The growth in the NGS data storage market is expected to be driven by the rising adoption of next-generation sequencing (NGS) tool in research laboratories that generates a huge amount of data that is stored and analyzed for actionable insights. Several companies have developed NGS informatics solutions to aid healthcare institutions and academic research centers.

Market Lifecycle Stage

NGS data is critical to researchers that offer storage solutions that are reliable while being easy to manage. Sequencing companies are adopting cloud-based storage solutions that offer several advantages, including accessibility, scalability, and cost-effectiveness. Cloud-based storage services are provided by various big IT vendors, such as Amazon Web Services, Google Cloud, and Microsoft Azure. These services offer pay-as-you-go models, which make it easier for researchers to manage costs based on their data storage needs.

Impact

NGS can be used to sequence the human genome and performed extensively in research laboratories during the COVID-19 pandemic. The technology generates an enormous amount of raw data that needs substantial amounts of computational processing to yield desired results. NGS also played a crucial role in advancing the research focused on tracing the origin of COVID-19. NGS bioinformatic pipeline was in practice during the pandemic that is defined as a series of data algorithms that are run to generate interpretable data. The technological methods of NGS are in high adoption in commercial laboratory processes and use inevitable variations in the software and computational tools. All NGS bioinformatics pipelines share several major features, including variant annotation sequence generation, variant identification, assembly and alignment, and variant visualization.

Impact of COVID-19

The SARS-CoV-2 virus changed multiple times during the pandemic through mutations and has a constantly evolving nature. Continuous monitoring of the viruses’ genomes is vital for the various diagnostic assays in different locations. Several non-commercial protocols and commercial kits were made available for amplicon SARS-CoV-2 preparation, some of which were adapted by NGS platforms. Leading market players in the NGS data storage market that offer NGS data analysis solutions are undertaking strategic partnerships and collaborations to refine their product portfolios and maintain a strong global NGS data storage market.

There was the adoption of a bioinformatics platform by research laboratories during the pandemic, and the virus is still being sequenced even during the post-pandemic era. For example, in early 2023, the latest variant of XBB.1.5, which is a subvariant of Omicron, has become the most transmissible strain of the COVID-19 virus so far. Thus, the need to keep sequencing this virus is constant. The pandemic has also spurred genome sequencing committees around the world, which are sequencing infectious diseases like never before. An enormous amount of NGS data is being produced, which requires effective data analysis and data storage. The petabyte (PB) and zettabyte (ZB) are required to process and analyze data in the life sciences and pharmaceutical industry. The demand for data storage is anticipated to increase more in the future with the rapid usage of cloud-based solutions offered by companies to understand the mechanism of coronavirus to prevent future outbreaks.

Market Segmentation:

Segmentation 1: by Read Length
• Short-read Length
• Long-read Length

Among the read length of the global NGS data storage market, the short-read length segment dominated in the year 2022. This is due to the rising adoption of short-read sequencing in research laboratories owing to its advantages, such as it is widely being used in diagnostic applications. The human genome is broken into small fragments, i.e., 50 to 300 bases, before it is sequenced. Short-read sequencing is cost-effective, accurate, and supported by a different range of data analysis pipelines and tools.

Segmentation 2: by Sourcing Type
• In-house NGS Data Storage
• Outsourced NGS Data Storage

Among the sourcing type of the global NGS data storage market, the in-house NGS data storage segment dominated in the year 2022, owing to increasing usage. In-house NGS data storage includes data analysis that involves those companies which are into the diagnosis of diseases. Such companies are carrying out NGS and their own data analysis using available software tools or servers or using available hardware and software resources. Companies operating in this segment have been increasing in the past few years.

Segmentation 3: by Offering
• Data Storage Solutions
• Data Analysis Services
• Other Offerings

Among the offerings type of the global NGS data storage market, data analysis services segment dominated in the year 2022. Bioinformaticians carry out data analysis services and the services can be customized depending on the customer’s requirements. Key aspects such as specific objectives, the approximate number of hours required for the project, and defined deliverables is estimated during the initial consultation by the bioinformaticians. Each data analysis service starts by consultation with an experienced NGS bioinformatics specialist in order to understand the customers requirements. Data analysis services deal with carrying out data analysis using software. For instance, Thermo Fisher Scientific, Inc. offers data analysis services using Torrent Suite Software. The company also offers a range of activities related to Ion AmpliSeq RNA or RNA-Seq data analysis and bioinformaticians guide their customer for these services.

Segmentation 4: by Application
• Oncology
• Infectious Diseases
• Rare Diseases
• Reproductive Health
• Central Nervous System (CNS)
• Other Applications

Among the applications of the global NGS data storage market, the oncology segment dominated in the year 2022. NGS technologies are efficient and accurate in detecting novel and rare somatic mutations. A variety of different types of cancers include bladder cancer, chronic lymphocytic, renal cell carcinoma, renal cell carcinoma, prostate cancer, small-cell lung cancer, and acute myelogenous. Cancer treatment is moving more toward targeted and personalized treatment. The five-year survival rate has improved significantly for many cancer types because of targeted therapies and immunotherapies.

Segmentation 5: by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East
• Rest-of-the-World

Among the region of the global NGS data storage market, North America dominated in the year 2022. The North America NGS data storage market is foreseen to be majorly driven by the presence of cloud-based and on-premise software solutions offered by NGS data storage companies to process, and store, large genomic and NGS datasets in the cloud with built-in scalability, thereby enhancing the overall scope of the market. The U.S. dominated the North America region because of substantial investments by the U.S. government for the co-development of targeted therapeutics and molecular diagnostics, the presence of major market players in the country, and significant healthcare expenditure in the region.

Recent Developments in the Global NGS Data Storage Market

• In March 2023, Illumina, Inc. launched its first product based on its long-read technology. The technology has high-performance, long-read sequencing technology that offers an application for whole-genome sequencing (WGS) assay, i.e., Illumina Complete Long Read Prep, Human, which is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems.

• In March 2023, Illumina, Inc. launched ‘Connected Insights Software,’ a new cloud-based software that helps in the tertiary analysis of clinical data. The software is being used by researchers for tertiary analysis for oncology applications and for rare diseases in the future.

• In February 2023, Twist Bioscience gained early access to the Twist enhanced Whole Genome Sequencing (eWGS) solution targeted on non-human genomics applications at the Advances in Genome Biology and Technology (AGBT) 2023 General Meeting in Hollywood, Florida. eWGS is a novel solution that helps researchers to enable low-pass whole genome data together of selected regions in a cost-effective and high throughput workflow.

• In January 2023, QIAGEN N.V. introduced the QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, and enhanced QIAGEN CLC Genomics Workbench Premium for a $1.0 computing cost for 25 minutes. The product helps to remove the data-analysis bottleneck of NGS by adding game-changing analysis speed to analyze and interpret whole exome sequencing (WES), whole genome sequencing (WGS), and large panel sequencing data.

• In October 2022, BGI Australia’s lab received the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing (WES) in Australia. The company paved the way for the global life sciences company to provide clinical sequencing services.

Demand – Drivers and Limitations

The following are the demand drivers for Global NGS Data Storage Market:

• Declining cost of cloud-based data storage solutions
• Increasing demand for sequencing at higher depth
• Growing number of population genomics studies and initiatives globally
• Rising adoption of cloud-based data storage solutions

The market is expected to face some limitations, too, due to the following challenges:

• Genomic data privacy and security concerns
• Increasing volume of data storage and its complexity

How can this report add value to an organization?

Innovation Strategy: Companies in the global NGS data storage market are involved in continuous innovation and strategy related to offering data analysis and data compression software solutions and services. For instance, In October 2021, VAST Data, Inc. introduced VASTOS version 4, its universal storage operating system, which has the capability to provide a range of enterprise security and management features designed to harden and simplify data management.

Growth/Marketing Strategy: Companies involved in the global NGS data storage market have received approval and certification from regulatory authorities. For instance, in October 2022, BGI Australia’s lab received the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing (WES) in Australia. The company paved the way for the global life sciences company to provide clinical sequencing services. The MGI DNBSEQ-G400 platform that performs clinical WES and the procedures implemented by the technicians of MGI have qualified for NATA accreditation. NATA’s certification for a laboratory is provided for storage and the process for data deletion, and these are a critical part of NATA’s certification.

Competitive Strategy: Key players in the global NGS data storage market are analyzed and profiled in the study to provide data storage solutions and services to their end users. Moreover, a detailed competitive benchmarking of the players operating in the global NGS data storage market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration. The leading top segment players include NGS data storage solutions and service providers. Also, other segments such as read length, sourcing type, workflow, application, and end-user in the market have been considered as part of the scope of the study.

Among the read length segment, the short-read length segment dominated in the year 2022 with a market share of 68.37%

Key Companies Profiled

• Agilent Technologies, Inc.
• BGI Group
• DNAnexus, Inc.
• Fabric Genomics, Inc.
• F. Hoffmann-La Roche Ltd. (Roche Molecular Systems, Inc.)
• Illumina, Inc.
• PerkinElmer Inc.
• PacBio.
• QIAGEN N.V.
• Qumulo, Inc.
• Thermo Fisher Scientific Inc.

The post NGS Data Storage Market – A Global and Regional Analysis: Focus on Offerings, Read Length, Sourcing Type, Application, End User, and Country Analysis – Analysis and Forecast, 2023-2033 first appeared on CRI Report.